On SNY’s 3Q10 CC, CEO Chris Viehbacher and COO Hanspeter Spek openly ridiculed Amphastar’s desperation in resorting to suing the FDA. They evidently didn’t see the irony in their remarks.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”